TY - CHAP
T1 - The dynamic roles of advanced glycation end products
AU - Khalid, Mariyam
AU - Adem, Abdu
N1 - Publisher Copyright:
© 2024
PY - 2024/1
Y1 - 2024/1
N2 - Advanced glycation end products (AGEs) are a heterogeneous group of potentially harmful molecules that can form as a result of a non-enzymatic reaction between reducing sugars and proteins, lipids, or nucleic acids. The total body pool of AGEs reflects endogenously produced AGEs as well as exogeneous AGEs that come from sources such as diet and the environment. Engagement of AGEs with their cellular receptor, the receptor for advanced glycation end products (RAGE), which is expressed on the surface of various cell types, converts a brief pulse of cellular activation to sustained cellular dysfunction and tissue destruction. The AGEs/RAGE interaction triggers a cascade of intracellular signaling pathways such as mitogen-activated protein kinase/extracellular signal-regulated kinase, phosphoinositide 3-kinases, transforming growth factor beta, c-Jun N-terminal kinases (JNK), and nuclear factor kappa B, which leads to the production of pro-inflammatory cytokines, chemokines, adhesion molecules, and oxidative stress. All these events contribute to the progression of several chronic diseases. This chapter will provide a comprehensive understanding of the dynamic roles of AGEs in health and disease which is crucial to develop interventions that prevent and mitigate the deleterious effects of AGEs accumulation.
AB - Advanced glycation end products (AGEs) are a heterogeneous group of potentially harmful molecules that can form as a result of a non-enzymatic reaction between reducing sugars and proteins, lipids, or nucleic acids. The total body pool of AGEs reflects endogenously produced AGEs as well as exogeneous AGEs that come from sources such as diet and the environment. Engagement of AGEs with their cellular receptor, the receptor for advanced glycation end products (RAGE), which is expressed on the surface of various cell types, converts a brief pulse of cellular activation to sustained cellular dysfunction and tissue destruction. The AGEs/RAGE interaction triggers a cascade of intracellular signaling pathways such as mitogen-activated protein kinase/extracellular signal-regulated kinase, phosphoinositide 3-kinases, transforming growth factor beta, c-Jun N-terminal kinases (JNK), and nuclear factor kappa B, which leads to the production of pro-inflammatory cytokines, chemokines, adhesion molecules, and oxidative stress. All these events contribute to the progression of several chronic diseases. This chapter will provide a comprehensive understanding of the dynamic roles of AGEs in health and disease which is crucial to develop interventions that prevent and mitigate the deleterious effects of AGEs accumulation.
KW - AGEs-related chronic diseases
KW - Advanced glycation end products (AGEs)
KW - Diabetic complications
KW - Dietary AGEs
KW - Inflammatory cytokines
KW - NF-κB
KW - Oxidative stress
KW - RAGE signaling
KW - Reactive carbonyl compounds
KW - Receptor for AGEs (RAGE)
UR - http://www.scopus.com/inward/record.url?scp=85194307165&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85194307165&partnerID=8YFLogxK
U2 - 10.1016/bs.vh.2024.02.008
DO - 10.1016/bs.vh.2024.02.008
M3 - Chapter
AN - SCOPUS:85194307165
SN - 9780443194023
T3 - Vitamins and Hormones
SP - 1
EP - 29
BT - Glycation
A2 - Litwack, Gerald
PB - Academic Press Inc.
ER -